StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Cytori Therapeutics, Inc.

Enter Symbol or Keywords

Cytori Therapeutics' OPS Ranking of "8" Reiterated by StockDiagnostics.com

Stock Quote: (NGM:CYTX)

11/20/2009

4.05

-0.27

-6.25%

1,557,404

Cytori Therapeutics' OPS Ranking of "8" Reiterated by StockDiagnostics.com

Last

Price Change

% Chg

Volume

Sarasota, FL, November 20, 2009-StockDiagnostics.com announced that it has reiterated its OPS Ranking of "8" for Cytori Therapeutics, Inc. (NASDAQ:CYTX). Cytori Therapeutics has had an OPS Ranking of ... read full story

Website Address:	www.cytoritx.com
Industry:	Biomaterial & Tissue Engineering

Most Recent STN Exclusives

11/04/2010

Cash Flow from Operations for SAP AG Reaches Nine Year High

11/04/2010

Macrovision Solutions' OPS Ranking of "2" Reiterated by StockDiagnostics.com

11/04/2010

Cash Flow from Operations for Pepco Holdings Reaches Four Year High

11/04/2010

Cash Flow from Operations Increases 151% for KLA-Tencor

11/04/2010

Seven Year High in Cash Flow from Operations for Dana Holding

11/04/2010

Public Service Enterprise's Cash Flow from Operations Increases 48%

11/04/2010

StockDiagnostics.com Reiterates Schlumberger Limited's OPS Ranking of "1"

11/04/2010

Free Cash Flow Turns Negative for Goodyear's Third Quarter

11/04/2010

Cash Flow from Operations for Waste Management Increases 17.7%

11/04/2010

Free Cash Flow for America Movil Reaches Three Year High

Interactive Chart: CYTX

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: CYTX

08/23/2010

EBITDA Turns Negative for Cytori Therapeutics' Second Quarter

08/20/2010

Cytori Therapeutics Experiencing Revenue Downtrend While its Industry is in an Uptrend

08/19/2010

OPS Ranking of "8" for Cytori Therapeutics Reiterated by StockDiagnostics.com

... more CYTX exclusives

Other News Sources: CYTX

01/30/2012

Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Trial; Investigational Device Exemption (IDE) Approved for ATHENA

01/24/2012

Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American College of Cardiology; Cytori's APOLLO Trial Demonstrated Safety & Feasibility and Improvements in Cardiac Function

01/09/2012

Stem Cell Therapy From Aastrom Biosciences and Cytori Therapeutics Looks to Gain Ground in 2012

... more CYTX news from other sources

Daily Market Updates

02/07/2012

Markets Close Higher with Utilities and Energy as Sector Leaders

U.S. markets ended higher despite the lack of an agreement again today in Greece. A meeting of coalition party leaders in Athens was postponed until tomorrow. Greek Prime Minister Lucas Papademos and the political leaders met again today to try to ag ... read full story